Multi-cell type human liver microtissues for hepatotoxicity testing

Archives of Toxicology

Volumn 87, Issue 1, 2013, Pages 209-213

  Messner, S ^a   Agarkova, I ^a   Moritz, W ^a   Kelm, J M ^a  

^a InSphero AG   (Switzerland)

Author keywords

3 dimensional; Kupffer cells; Spheroids

Indexed keywords

DICLOFENAC; LIPOPOLYSACCHARIDE; PARACETAMOL; TROVAFLOXACIN;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; INFLAMMATION; KUPFFER CELL; LIVER CELL; LIVER TOXICITY; PRIORITY JOURNAL; TOXICITY TESTING;

FLUOROQUINOLONES; HEPATOCYTES; HUMANS; KUPFFER CELLS; LIPOPOLYSACCHARIDES; NAPHTHYRIDINES; TISSUE CULTURE TECHNIQUES; TOXICITY TESTS;

EID: 84872301011     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0968-2     Document Type: Article

References (12)

1. Berthiaume F et al (1996) Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J 10(13):1471-1484
2. Bort R et al (1999) Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J Pharmacol Exp Ther 288(1):65-72
3. Fey SJ, Wrzesinski K (2012) Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line. Toxicol Sci 127(2):403-411
4. Hartung T (2009) Toxicology for the twenty-first century. Nature 460(7252): 208-212 http://www.ncbi.nlm.nih.gov/pubmed/19587762
5. Kelm JM, Fussenegger M (2004) Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 22(4):195-202
6. Lecluyse EL et al (2012) Organotypic liver culture models: Meeting current challenges in toxicity testing. Crit Rev Toxicol 42(6):501-548
7. Liguori MJ et al (2010) Comparison of TNFa to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: trovafloxacin as an example. Int J Mol Sci 11(11):4697-4714
8. Olson H et al (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32(1):56-67
9. Park KB et al (2005) The role of metabolic activation in drug-induced hepatotoxicity. Annu Rev Pharmacol Toxicol 45(1):177-202
10. Shaw PJ et al (2007) Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci 100(1):259-266
11. Shaw PJ, Ganey PE, Roth R (2010) Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci 118(1):7-18
12. Stine JG, Lewis JH (2011) Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Toxicol 7(7):875-890